Full Text View
Tabular View
No Study Results Posted
Related Studies
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major (DFODFPTM)
This study has been completed.
Study NCT00800761   Information provided by Ospedale Microcitemico

First Received on December 1, 2008.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Iron Overload
Cardiomyopathy
Additional conditions recognized in this trial
Beta-Thalassemia
Cardiomyopathies
Heart Diseases
Thalassemia
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Cardiovascular Diseases
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Iron Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Deferoxamine and Deferiprone
Deferoxamine
Additional drug interventions recognized in this trial
Deferiprone
More general drug interventions related to this trial
Chelating Agents
Iron Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Siderophores
Sponsors listed in this trial
Ospedale Microcitemico
ASL Cagliari


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services